141 related articles for article (PubMed ID: 10905582)
1. The role of nitric oxide in the reduction of protein kinase C-induced contractile response in aortae from rats with portal hypertension.
Chagneau C; Tazi KA; Heller J; Sogni P; Poirel O; Moreau R; Lebrec D
J Hepatol; 2000 Jul; 33(1):26-32. PubMed ID: 10905582
[TBL] [Abstract][Full Text] [Related]
2. Abnormal regulation of aortic NOS2 and NOS3 activity and expression from portal vein-stenosed rats after lipopolysaccharide administration.
Heller J; Sogni P; Tazi KA; Chagneau C; Poirel O; Moreau R; Lebrec D
Hepatology; 1999 Sep; 30(3):698-704. PubMed ID: 10462376
[TBL] [Abstract][Full Text] [Related]
3. Vascular contractile response and signal transduction in endothelium-denuded aorta from cirrhotic rats.
Lin HC; Yang YY; Huang YT; Lee TY; Hou MC; Lee FY; Lee SD
World J Gastroenterol; 2005 Apr; 11(15):2306-12. PubMed ID: 15818743
[TBL] [Abstract][Full Text] [Related]
4. Endothelial calcium-calmodulin dependent nitric oxide synthase in the in vitro vascular hyporeactivity of portal hypertensive rats.
Gadano AC; Sogni P; Yang S; Cailmail S; Moreau R; Nepveux P; Couturier D; Lebrec D
J Hepatol; 1997 Mar; 26(3):678-86. PubMed ID: 9075677
[TBL] [Abstract][Full Text] [Related]
5. Altered prostacyclin synthesis by aortae from hepatic portal vein-constricted rats: evidence for effects on protein kinase C and calcium.
Jeremy JY; Mikhailidis DP; Karatapanis S; Harry D; Burroughs AK; McIntyre N; Stansby G; Jacobs M; McCormick A
J Hepatol; 1994 Dec; 21(6):1017-22. PubMed ID: 7699222
[TBL] [Abstract][Full Text] [Related]
6. Octreotide potentiates PKC-dependent vasoconstrictors in portal-hypertensive and control rats.
Wiest R; Tsai MH; Groszmann RJ
Gastroenterology; 2001 Mar; 120(4):975-83. PubMed ID: 11231951
[TBL] [Abstract][Full Text] [Related]
7. The role of increased nitric oxide in the vascular hyporeactivity to noradrenaline in long-term portal vein ligated rats.
Michielsen PP; Boeckxstaens GE; Sys SU; Herman AG; Pelckmans PA
J Hepatol; 1995 Sep; 23(3):341-7. PubMed ID: 8550999
[TBL] [Abstract][Full Text] [Related]
8. Role of nitric oxide in hyporeactivity to noradrenaline of isolated aortic rings in portal hypertensive rats.
Michielsen PP; Boeckxstaens GE; Sys SU; Herman AG; Pelckmans PA
Eur J Pharmacol; 1995 Jan; 273(1-2):167-74. PubMed ID: 7537679
[TBL] [Abstract][Full Text] [Related]
9. Aminoguanidine reverses aortic hyporeactivity to noradrenaline in portal vein-ligated rats.
Michielsen PP; Boeckxstaens GE; Sys SU; Herman AG; Pelckmans PA
Eur J Pharmacol; 1997 Jun; 329(2-3):137-46. PubMed ID: 9226406
[TBL] [Abstract][Full Text] [Related]
10. Vascular nitric oxide production during the development of two experimental models of portal hypertension.
Gadano AC; Sogni P; Heller J; Moreau R; Bories PN; Lebrec D
J Hepatol; 1999 May; 30(5):896-903. PubMed ID: 10365818
[TBL] [Abstract][Full Text] [Related]
11. Role of protein kinase C in mesenteric pressor responses of rats with portal hypertension.
Atucha NM; Ortíz MC; Martínez C; Quesada T; García-Estañ J
Br J Pharmacol; 1996 May; 118(2):277-82. PubMed ID: 8735627
[TBL] [Abstract][Full Text] [Related]
12. Hyporeactivity of mesenteric resistance arteries in portal hypertensive rats.
Sogni P; Sabry S; Moreau R; Gadano A; Lebrec D; Dinh-Xuan AT
J Hepatol; 1996 Apr; 24(4):487-90. PubMed ID: 8738736
[TBL] [Abstract][Full Text] [Related]
13. Alteration in vascular reactivity in isolated aortic rings from portal vein-constricted rats.
Karatapanis S; McCormick PA; Kakad S; Chin JK; Islam M; Jeremy J; Harry D; McIntyre N; Burroughs AK; Jacobs M
Hepatology; 1994 Dec; 20(6):1516-21. PubMed ID: 7527005
[TBL] [Abstract][Full Text] [Related]
14. Dose-dependent effects of a nitric oxide biosynthesis inhibitor on hyperdynamic circulation in two models of portal hypertension in conscious rats.
Pilette C; Kirstetter P; Sogni P; Cailmail S; Moreau R; Lebrec D
J Gastroenterol Hepatol; 1996 Jan; 11(1):1-6. PubMed ID: 8672735
[TBL] [Abstract][Full Text] [Related]
15. Renal response to methoxamine in portal hypertensive rats: role of prostaglandins and nitric oxide.
García-Estañ J; Atucha NM; Groszmann RJ
J Hepatol; 1996 Aug; 25(2):206-11. PubMed ID: 8878783
[TBL] [Abstract][Full Text] [Related]
16. Role of aortic nitric oxide synthase 3 (eNOS) in the systemic vasodilation of portal hypertension.
Pateron D; Tazi KA; Sogni P; Heller J; Chagneau C; Poirel O; Philippe M; Moreau R; Lebrec D
Gastroenterology; 2000 Jul; 119(1):196-200. PubMed ID: 10889169
[TBL] [Abstract][Full Text] [Related]
17. Mesenteric vasoconstriction triggers nitric oxide overproduction in the superior mesenteric artery of portal hypertensive rats.
Tsai MH; Iwakiri Y; Cadelina G; Sessa WC; Groszmann RJ
Gastroenterology; 2003 Nov; 125(5):1452-61. PubMed ID: 14598261
[TBL] [Abstract][Full Text] [Related]
18. Functional study of the [Ca2+]i signaling pathway in aortas of L-NAME-hypertensive rats.
de Campos Grifoni S; Bendhack LM
Pharmacology; 2004 Mar; 70(3):160-8. PubMed ID: 14752236
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide-dependent and -independent vascular hyporeactivity in mesenteric arteries of portal hypertensive rats.
Heinemann A; Wachter CH; Holzer P; Fickert P; Stauber RE
Br J Pharmacol; 1997 Jul; 121(5):1031-7. PubMed ID: 9222564
[TBL] [Abstract][Full Text] [Related]
20. Increased gastric bicarbonate secretion in portal hypertensive anesthetized rats: role of prostaglandins and nitric oxide.
Lamarque D; Dutreuil C; Dhumeaux D; Delchier JC
Dig Dis Sci; 1997 Apr; 42(4):743-50. PubMed ID: 9125643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
